Ondansetron Versus Aprepitant Plus Ondansetron for Emesis

Clinical trial NCT00954941 · COMPLETED

Trial details

NCT number: NCT00954941
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematologic Diseases Acute Myelogenous Leukemia Myelodysplastic Syndrome Chronic Myelogenous Leukemia

Start date: 2009-11-01
Primary completion: 2013-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.